Question 1

What is the catalog number for Brain metastatic carcinoma tissue array, including pathology grade, 43 cases/86 cores, replacing GL861-GL861a?

Accepted Answer

The catalog number for Brain metastatic carcinoma tissue array, including pathology grade, 43 cases/86 cores, replacing GL861-GL861a is GL861a.

Question 2

Is Brain metastatic carcinoma tissue array, including pathology grade, 43 cases/86 cores, replacing GL861-GL861a in stock?

Accepted Answer

Brain metastatic carcinoma tissue array, including pathology grade, 43 cases/86 cores, replacing GL861-GL861a is currently made to order / not held in immediate stock. Contact us for lead time.

Question 3

What is Brain metastatic carcinoma tissue array, including pathology grade, 43 cases/86 cores, replacing GL861-GL861a used for?

Accepted Answer

Brain metastatic carcinoma tissue microarray, containing 43 cases metastatic carcinoma, duplicate core per case

Question 4

What dilution range is recommended for immunohistochemistry (IHC) with this antibody?

Accepted Answer

A starting IHC dilution range is listed on the datasheet, but should be optimized for your specific tissue type and staining protocol.

Question 5

Can I request a Safety Data Sheet (SDS) for this product?

Accepted Answer

Yes, safety data sheets are available for hazardous or chemically classified products and can be provided on request or downloaded from the product page.

Question 6

Can this product be used for co-immunoprecipitation (Co-IP)?

Accepted Answer

Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.

Brain metastatic carcinoma tissue array, including pathology grade, 43 cases/86 cores, replacing GL861-GL861a

Product Specifications

Sample Type

Cases

Cores

Frequently Asked Questions

Explore Other Products

RAGE Recombinant Rabbit Monoclonal Antibody [JF0975]

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), Biotin conjugate, 0.1mg/mL

P53 Tumor Suppressor Protein (DO-1), CF594 conjugate, 0.1mg/mL

Anti-SMURF 2/SMURF2 Antibody Picoband® (Biotine Conjugate)

PAX5 / BSAP (Early B-Cell Marker) (PCRP-PAX5-1B1), CF405S conjugate, 0.1mg/mL

Insulin / IRDN (beta-Cell & Insulinoma Marker) (K36aC10), CF568 conjugate, 0.1mg/mL